BeiGene Ownership | Who Owns BeiGene?

Overview Forecast RevenueFinancials Chart Transcripts

BeiGene Ownership Summary

BeiGene is owned by 0.80% institutional investors, 19.43% insiders, and 79.77% retail investors. Capital investors is the largest institutional shareholder, holding 5.77% of BGNE shares. American Funds New Perspective A is the top mutual fund, with 2.63% of its assets in BeiGene shares.

BGNE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	BeiGene	0.80%	19.43%	79.77%
Sector	Healthcare Stocks	279.18%	10.62%	-189.80%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital investors	6.11M	5.77%	$1.13B
Primecap management co/ca/	5.10M	4.81%	$941.82M
Baillie gifford	3.67M	3.47%	$678.11M
Price t rowe associates inc /md/	2.94M	2.77%	$542.52M
Fmr	1.85M	1.75%	$341.36M
Temasek (private)	1.53M	1.44%	$281.74M
Blackrock	959.19K	0.71%	$136.85M
Blackrock funding, inc. /de	733.98K	0.69%	$135.57M
Baker bros. advisors lp	8.80M	0.63%	$2.39B
Siren	653.72K	0.62%	$120.75M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Baker bros. advisors lp	8.80M	26.50%	$2.39B
Paradigm biocapital advisors lp	666.02K	8.30%	$181.27M
Hhlr advisors	1.03M	7.95%	$281.51M
Siren	653.72K	5.33%	$120.75M
Jgp global gestao de recursos ltda.	9.37K	3.94%	$1.73B
Boxer capital	500.00K	3.76%	$71.33M
Nan fung group	20.00K	3.16%	$3.69M
Long corridor asset management	18.40K	2.55%	$3.40M
Xy capital	24.60K	2.19%	$4.54M
Exome asset management	6.50K	1.57%	$1.77M

Top Buyers

Holder	Shares	% Assets	Change
Nuveen asset management	405.21K	0.02%	242.56K
Price t rowe associates inc /md/	2.94M	0.06%	237.08K
Fmr	1.85M	0.02%	188.05K
Driehaus capital management	180.96K	0.47%	171.17K
Primecap management co/ca/	5.10M	0.73%	124.61K

Top Sellers

Holder	Shares	% Assets	Change
Hhlr advisors	1.03M	7.95%	-2.77M
Temasek (private)	1.53M	1.11%	-863.25K
Baker bros. advisors lp	8.80M	26.50%	-732.83K
Point72 asset management	25.17K	0.01%	-642.00K
Vestal point capital, lp	-	-	-350.00K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	100.01K	0.00%	100.01K	$18.47M
Healthcare of ontario pension plan trust fund	87.20K	0.03%	87.20K	$16.11M
Canada pension plan investment board	50.00K	0.01%	50.00K	$9.24M
Balyasny asset management	44.29K	0.01%	44.29K	$8.18M
Casdin capital	40.00K	0.89%	40.00K	$10.89M

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Central trust	-1.00
Advisornet financial	-2.00
Concourse financial group securities	-3.00
Pacific capital wealth advisors	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	15	-93.59%	11,120,804	-74.54%	-	0.05%	10	-91.15%	3	-96.05%
Dec 31, 2024	230	-3.36%	43,657,183	-6.07%	41	2.14%	111	1.83%	75	-12.79%
Sep 30, 2024	234	14.15%	46,472,316	-0.63%	43	3.69%	107	17.58%	84	27.27%
Jun 30, 2024	203	-1.93%	46,765,610	0.79%	34	1.75%	90	-29.69%	65	41.30%
Mar 31, 2024	207	-0.96%	46,399,493	3.32%	44	4.08%	128	37.63%	46	-37.84%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds New Perspective A	2.80M	2.63%	-
Capital Group New Perspective Comp	2.80M	2.63%	-
Vanguard PRIMECAP Inv	2.31M	2.16%	105.00K
American Funds New World A	1.16M	1.08%	-
Capital Group New Geography Equity Comp	1.16M	1.08%	-
Vanguard Capital Opportunity Inv	1.12M	1.05%	37.50K
T. Rowe Price Health Sciences	725.72K	0.68%	-17.51K
PRIMECAP Odyssey Aggressive Growth	698.89K	0.66%	-6.07K
T. Rowe Price International Gr Eq Tr-D	673.60K	0.63%	86.03K
PRIMECAP Odyssey Growth	671.43K	0.63%	-12.30K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 13, 2025	Wang Xiaodong	Chair, Scientific Advisory Brd	Sell	$2.27M
May 13, 2025	Wang Xiaodong	Chair, Scientific Advisory Brd	Sell	$45.14K
May 13, 2025	Wang Xiaodong	Chair, Scientific Advisory Brd	Sell	$2.28M
May 13, 2025	Wang Xiaodong	Chair, Scientific Advisory Brd	Sell	$4.74M
Apr 14, 2025	Wang Xiaodong	Chair, Scientific Advisory Brd	Sell	$1.33M

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	21
2025 Q1	-	87
2024 Q4	-	47
2024 Q3	-	12
2024 Q2	-	38

BGNE Ownership FAQ

Who Owns BeiGene?

BeiGene shareholders are primarily institutional investors at 0.80%, followed by 19.43% insiders and 79.77% retail investors. The average institutional ownership in BeiGene's industry, Biotech Stocks , is 63.96%, which BeiGene falls below.

Who owns the most shares of BeiGene?

BeiGene’s largest shareholders are Capital investors (6.11M shares, 5.77%), Primecap management co/ca/ (5.1M shares, 4.81%), and Baillie gifford (3.67M shares, 3.47%). Together, they hold 14.05% of BeiGene’s total shares outstanding.

Does Blackrock own BeiGene?

Yes, BlackRock owns 0.71% of BeiGene, totaling 959.19K shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 136.85M$. In the last quarter, BlackRock increased its holdings by 10.52K shares, a 1.11% change.

Who is BeiGene’s biggest shareholder by percentage of total assets invested?

Baker bros. advisors lp is BeiGene’s biggest shareholder by percentage of total assets invested, with 26.50% of its assets in 8.8M BeiGene shares, valued at 2.39B$.

Who is the top mutual fund holder of BeiGene shares?

American Funds New Perspective A is the top mutual fund holder of BeiGene shares, with 2.63% of its total shares outstanding invested in 2.8M BeiGene shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools